BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25705883)

  • 21. Bone dynamics and inflammation: lessons from rare diseases.
    Matsumoto Y; Rottapel R
    Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.
    Levaot N; Simoncic PD; Dimitriou ID; Scotter A; La Rose J; Ng AH; Willett TL; Wang CJ; Janmohamed S; Grynpas M; Reichenberger E; Rottapel R
    J Clin Invest; 2011 Aug; 121(8):3244-57. PubMed ID: 21765218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.
    de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):378-81. PubMed ID: 17321449
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel mutation in the SH3BP2 gene causes cherubism: case report.
    Li CY; Yu SF
    BMC Med Genet; 2006 Dec; 7():84. PubMed ID: 17147794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating global gene expression changes in a murine model of cherubism.
    Sharma T; Cotney J; Singh V; Sanjay A; Reichenberger EJ; Ueki Y; Maye P
    Bone; 2020 Jun; 135():115315. PubMed ID: 32165349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
    Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
    J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
    Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
    Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The adaptor protein 3BP2 in leukocyte signaling].
    Deckert M
    Med Sci (Paris); 2006 Dec; 22(12):1081-6. PubMed ID: 17156730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
    Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
    Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
    Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
    Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the SH3BP2 gene mutation in cherubism.
    Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
    Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
    Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
    Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutation detection in SH3BP2 gene in a cherubism family].
    Li CY; Yu SF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16836910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cherubism. A case report.
    Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
    Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
    Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
    Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
    Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
    Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.
    Matsumoto Y; Rottapel R
    Trends Mol Med; 2023 May; 29(5):390-405. PubMed ID: 36948987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
    Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
    Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
    Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.